Veerhealth Care Limited, a rising force in Ayurvedic and cosmetic healthcare, has inked a pivotal contract manufacturing agreement to produce personal care products for a leading institutional client in the United States. This move marks a significant milestone in the company’s international expansion strategy and positions it to capitalize on the growing global demand for Ayurvedic and herbal formulations.
New Contract Manufacturing Agreement
-
Veerhealth Care has secured a contract to manufacture and supply personal care products, including oral care items, for a top-tier US institutional buyer.
-
The initial order is valued at approximately USD 50,000 (₹41.5 lakh) and is scheduled for execution in Q4 FY23–24.
-
The company anticipates repeat monthly orders following successful delivery of the sample batch.
Product Portfolio and Market Focus
-
The agreement includes the production of Ayurvedic and cosmetic-grade oral care products, such as herbal toothpaste, which are free from harmful chemicals and rich in natural extracts.
-
Veerhealth Care is also eyeing expansion into body care and skincare segments in the US market, leveraging the growing Western interest in Indian Ayurvedic solutions.
Manufacturing Capabilities and Certifications
-
All products will be manufactured at the company’s state-of-the-art facility in Vapi, Gujarat, which spans 60,000 sq ft and complies with ISO 9001:2015, Ayurvedic GMP, and Cosmetic GMP standards.
-
The company is in the final stages of securing US FDA approval for this facility, which will further enhance its credibility in regulated markets.
Expansion and Infrastructure Investment
-
Veerhealth Care is acquiring an additional 27,451 sq ft of land adjacent to its current plant to establish new CGMP-compliant manufacturing lines.
-
A ₹33 crore expansion plan is underway, covering land acquisition, machinery procurement, and infrastructure development to meet rising global demand.
Financial Outlook and Growth Ambitions
-
In FY23, the company reported revenues of ₹13.27 crore and a PAT of ₹1.58 crore.
-
Management has set an ambitious target to scale revenues to ₹100 crore with a 10% PAT margin over the next 3–4 years, driven by international orders and private-label manufacturing.
Brand and Clientele
-
Veerhealth Care operates under its proprietary brand AYUVEER, offering a wide range of personal care products across e-commerce and offline retail channels.
-
The company already serves major Indian pharmacy chains like Apollo Pharmacy and DavaIndia and is now extending its reach to global institutional clients.
Conclusion: This contract manufacturing agreement is more than a commercial win—it’s a strategic leap for Veerhealth Care into the global wellness arena. With a robust manufacturing backbone, expanding product lines, and a clear vision for international growth, the company is poised to become a key player in the Ayurvedic and herbal personal care segment worldwide.
Sources: Business India, Bastion Research, Veerhealth Care Press Release (BSE), veerhealthcare.net